Fundz

Connect Biopharma Completes $115 Million Series C Financing to Advance Ongoing Clinical Trials in Atopic Dermatitis and Ulcerative Colitis and Initiate Additional Clinical Programs

PRIVATEAug 24, 2020

Amount Raised

$115 Million

Round Type

Series C

San DiegoBiotechnologyTherapeuticsBiopharma

Description

Connect Biopharma ("Connect"), a clinical-stage biopharmaceutical company focused on identifying and developing potent and specific immune modulating molecules, today announced the completion of a $115 million Series C financing led by new investor RA Capital Management. Additional new investors Lilly Asia Ventures, Boxer Capital, and HBM Healthcare Investments joined existing investor Qiming Venture Partners in the financing. The company also announced that, in conjunction with the financing, Derek DiRocco, PhD, Principal at RA Capital Management, is joining the Connect Biopharma Board of Directors.

Quick answer

Cbp 201 raised $115 Million in a Series C round, dated August 24, 2020. Cbp 201 is based in San Diego, California, United States.

How much did Cbp 201 raise?
Cbp 201 raised $115 Million in a Series C round on August 24, 2020.
What does Cbp 201 do?
Connect Biopharma is a global, clinical-stage biopharmaceutical company applying its expertise in T cell biology and deep knowledge of the drug discovery industry to develop innovative therapies to treat chronic..
Where is Cbp 201 based and how big is it?
Cbp 201 is based in San Diego, California, United States.

Source: Fundz verified event record.

Who else raised in Therapeutics and Biopharma around the same time

Companies in the same sectors as Cbp 201 that raised within 45 days of this round, from Fundz verified event records.

  • OnKure Therapeutics raised $1.5M (Seed) on September 30, 2020.
  • Oragenics raised an undisclosed amount (Funding Round) on September 28, 2020.
  • LAVA Therapeutics raised $83M (Series C) on September 17, 2020.
  • BioNTech raised $250M on September 17, 2020.
  • Adipo Therapeutics raised $1.3M (Seed) on September 2, 2020.
  • AEON Biopharma raised $25M on August 31, 2020.

Who to call at Cbp 201, and when

A new round usually means Cbp 201 is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Cbp 201 raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Cbp 201, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Cbp 201. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Cbp 201

Location

San Diego, California, United States

About

Connect Biopharma is a global, clinical-stage biopharmaceutical company applying its expertise in T cell biology and deep knowledge of the drug discovery industry to develop innovative therapies to treat chronic inflammatory diseases with the goal of improving the lives of millions of those affected around the world. The Company is building a rich pipeline of proprietary small molecules and antibodies, using functional T cell assays, to screen and discover potent product candidates against validated immune targets.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Cbp 201 raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for Cbp 201's next move

See what Strategic adds

Cbp 201 raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.